Related references
Note: Only part of the references are listed.Outbreaks of virulent diarrheagenic Escherichia coli - are we in control?
Dirk Werber et al.
BMC MEDICINE (2012)
Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota
Kirk E. Smith et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis
Somshuvra Mukhopadhyay et al.
SCIENCE (2012)
Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic Syndrome
Christina A. Hickey et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2011)
Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans
David J. Asper et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
The 2011 Shiga toxin-producing Escherichia coli O104:H4 German outbreak: a lesson in genomic plasticity
E. Denamur
CLINICAL MICROBIOLOGY AND INFECTION (2011)
In Vivo Leukocyte Changes Induced by Escherichia coli Subtilase Cytotoxin
Hui Wang et al.
INFECTION AND IMMUNITY (2011)
B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate
Cheng-song Wan et al.
MICROBIOLOGY AND IMMUNOLOGY (2011)
Eculizumab in Severe Shiga-Toxin-Associated HUS
Anne-Laure Lapeyraque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Open-Source Genomic Analysis of Shiga-Toxin-Producing E. coli O104:H4
Holger Rohde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interactions with M Cells and Macrophages as Key Steps in the Pathogenesis of Enterohemorragic Escherichia coli Infections
Lucie Etienne-Mesmin et al.
PLOS ONE (2011)
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide
Deborah J. Stearns-Kurosawa et al.
PEDIATRIC NEPHROLOGY (2011)
Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice
Jiang Gu et al.
VACCINE (2011)
Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection
Kun Cai et al.
VACCINE (2011)
Acute Renal Replacement Therapy in Children with Diarrhea-Associated Hemolytic Uremic Syndrome: A Single Center 16 Years of Experience
Silviu Grisaru et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response
Kun Cai et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2010)
An Orally Applicable Shiga Toxin Neutralizer Functions in the Intestine To Inhibit the Intracellular Transport of the Toxin
Miho Watanabe-Takahashi et al.
INFECTION AND IMMUNITY (2010)
A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model
Leticia V. Bentancor et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome
Joshua M. Thurman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome
Dorothea Orth et al.
JOURNAL OF IMMUNOLOGY (2009)
Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics against Escherichia coli O157:H7 Infection
Quanshun Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice
Jiang Gu et al.
MICROBES AND INFECTION (2009)
Management of diarrhea-associated hemolytic uremic syndrome in children
Kazumoto Iijima et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2008)
The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate
P. Tiels et al.
VACCINE (2008)
Characterization of the StcE protease activity of Escherichia coli O157:H7
Thomas E. Grys et al.
JOURNAL OF BACTERIOLOGY (2006)
A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2
SX Wen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice
DG Motto et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Bovine feces from animals with gastrointestinal infections are a source of serologically diverse atypical enteropathogenic Escherichia coli and Shiga toxin-producing E-coli strains that commonly possess intimin
MA Hornitzky et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation
K Nishikawa et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Relative nephroprotection during Escherichia coli O157:H7 infections:: Association with intravenous volume expansion
JA Ake et al.
PEDIATRICS (2005)
The diversity of Escherichia coli serotypes and biotypes in cattle faeces
KA Bettelheim et al.
JOURNAL OF APPLIED MICROBIOLOGY (2005)
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial
H Trachtman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx2-EDL933 and/or stx2vhb subtypes
KN Brett et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7:: Characterization and evolutionary considerations
A Janka et al.
INFECTION AND IMMUNITY (2003)
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
SL Allford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis -: A meta-analysis
N Safdar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients
H Kulkarni et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2002)
Inhibitory activity of Bifidobacterium longum HY8001 against vero cytotoxin of Escherichia coli O157:H7
SH Kim et al.
JOURNAL OF FOOD PROTECTION (2001)
Neutralization of shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose
AW Paton et al.
INFECTION AND IMMUNITY (2001)
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
CS Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice
XP Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
